PsychU Community Podcast: Recent Episodes
PsychU
PsychU is a free community and online resource library for mental health. Our podcast’s goal is to share information, increase collaboration, and foster ongoing discussions that will lead to improved mental health care and patient outcomes for individuals with mental illness. Each monthly episode provides scientific, evidence-based, educational information related to mental health, featuring thought leaders dedicated to improving mental health care… together. Learn more at www.PsychU.org. Speakers may be paid consultants or employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. When conducting medical dialogue, whether by presentation or debate, OPDC/Lundbeck and/or its paid consultants aim to provide the viewer with information that is accurate, not misleading, scientifically rigorous, and does not promote OPDC/Lundbeck products. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
In this podcast, Dr. Joseph Goldberg will delve into how co-occurring psychiatric conditions influence patient health. A comprehensive understanding and effective management of these comorbidities are crucial for optimizing patient care and enhancing long-term outcomes.
This podcast contains highlights from the On-Demand Webinar “Exploring Post-Traumatic Stress Disorder: Treatment Landscape & Unmet Needs” featuring Dr. David Block. The conversation explores the current landscape of PTSD treatment, covering both psychotherapy and pharmacotherapy. It also discusses the limitations and key considerations involved in treating PTSD.
In this podcast, Dr Joseph Goldberg and Dr. John Meyers explore ways of interviewing patients with bipolar disorder to identify symptoms of mania and depression.
In this podcast, Dr. Roger McIntyre reviews the history of mixed states and mixed features, focusing on conceptualization, phenomenology, diagnostic considerations and treatment options.
This podcast is a continuation of the on-demand webinar entitled ‘Treatment Pathways Across Cultures’ that was aired on November 14, 2024, which featured Dr. Mauricio Tohen and Dr. Crystal Clark sharing their expert opinions on how cultural and ethnic backgrounds influence patient care for psychiatric disorders like bipolar I disorder.
Listen to Amica Simmons-Yon, PharmD, PhD as she spills the tea on a new Talking Points Series from Primary Care on Agitation associated with Alzheimer’s Dementia (AAD). In Part III of this series, our special guest, David E. Lewis, D.O. describes how he acknowledges and addresses Agitation in the primary care setting. He discusses practical points around the prominent AAD symptoms observed, the challenges he hears from patients and/or caregivers regarding AAD, and key points that he shares with patients about their diagnosis while bridging the gap to their mental health provider. Don’t forget to check out the Shownotes for links to PsychU resources and where you can learn more about this hot topic!
Listen to Amica Simmons-Yon, PharmD, PhD as she spills the tea on a new Talking Points Series from Primary Care on Major Depressive Disorder (MDD) with special guest, David E. Lewis, D.O. In Part II of this series, Dr. Lewis describes how he acknowledges and addresses MDD in the primary care setting. He discusses practical points around the prominent depressive symptoms observed, the challenges he hears from patients and/or caregivers regarding MDD, and key points that he shares with patients about their MDD diagnosis while bridging the gap to their mental health provider. Don’t forget to check out the Shownotes for links to PsychU resources and where you can learn more about this hot topic!
This podcast is a continuation of the on-demand webinar entitled ‘Comorbidities in Patients Living with Bipolar I Disorder’ that was aired on March 28, 2024, which featured Dr. Joseph Goldberg sharing his expert opinion on the complexities of psychiatric comorbidities associated with bipolar I disorder. Please listen in as Dr. Goldberg addresses many of the questions submitted by the audience during the on-demand webinar.
During this episode, Dr. Olele describes the different dimensions of wellness and discusses potential strategies to consider for underserved patients with Major Depressive Disorder (MDD) or Post-Traumatic Stress Disorder (PTSD). He will also share some key resources with listeners and where they can learn more about this hot topic!
Listen to Amica Simmons-Yon, PharmD, PhD as she spills the tea on mental health in rural America with special guest, Jeff Winton (Founder of Rural Minds). During this episode, Jeff Winton discusses the vision and mission of the non-profit organization, Rural Minds. Mr. Winton highlights the challenges and differences around mental health for those living in rural America. Lastly, Jeff Winton will also describe the future goals and initiative of Rural Minds and share key resources with listeners about this hot topic!
Listen to Amica Simmons-Yon, PharmD, PhD as she spills the tea on a new Talking Points Series from Primary Care on Post-Traumatic Stress Disorder (PTSD) with special guest, David E. Lewis, D.O. In Part I of this series, Dr. Lewis describes how he acknowledges and addresses PTSD in the primary care setting. He discusses practical points around the prominent PTSD symptoms he has observed, the challenges he hears from patients and/or caregivers regarding PTSD, and key points that he shares with patients about their diagnosis while bridging the gap to their mental health provider. Don’t forget to check out the Shownotes for links to PsychU resources and where you can learn more about this hot topic!
Listen to Amica Simmons-Yon, PharmD, PhD as she spills the tea on Narrative Enhancement and Cognitive Therapy (NECT) with special guest, Philip T. Yanos, PhD. During this episode, Dr. Yanos defines self-stigma, discusses the development of NECT, and who this therapy may be appropriate for. Lastly, Dr. Yanos will also share some key resources with listeners and where they can learn more about this hot topic!Featuring: •Philip T. Yanos, PhD; Professor, Department of Psychology John Jay College of Criminal Justice, City University of New York•Amica Simmons-Yon, PharmD, PhD; Senior Medical Science Liaison, OPDCResources:•NECT Global:•PsychU Stigma Resource Library: https://go.psychu.org/MgfU•Global Anti-Stigma Alliance (antistigma.global): http://antistigma.global/•Lab Mission (cuny.edu): https://mhrecoverylab.commons.gc.cuny.edu/•Narrative Enhancement and Cognitive Therapy (NECT) for Adults: https://www.youtube.com/watch?v=7KK3svQnh3M•Search | NAMI: National Alliance on Mental Illness: https://www.nami.org/?swp_form[form_id]=2&s=•Search | Mental Health America (mhanational.org): https://mirecc.va.gov/mirecc/visn5/training/ess/ESS.asp•VISN 5 MIRECC - Ending Self Stigma (ESS) Resources & Manual - MIRECC / CoE (va.gov): https://mirecc.va.gov/mirecc/visn5/training/ess/ESS.aspPhilip T. Yanos, PhD is a consultant of Otsuka Pharmaceutical Development & Commercialization, Inc (unpaid)Amica Simmons-Yon is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck LLC – committed supporters of the mental health treatment community. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Aneta Fornal, PharmD as they spill the tea on Agitation in Alzheimer’s Dementia with special guest, Marc Agronin, MD. During this episode, Dr. Agronin defines agitation, discusses management strategies, and the impact of agitation on both patients and caregivers. Lastly, Dr. Agronin will also share some key resources with listeners and where they can read more about this hot topic! Featuring: •Marc Agronin, MD; Chief Medical Officer, Miami Jewish MIND Institute; Associate Professor of Psychiatry & Neurology, University of Miami School of Medicine •Amica Simmons-Yon, PharmD, PhD; Senior Medical Science Liaison, OPDC •Aneta Fornal, PharmD; Medical Science Director, OPDCResources•PsychU Infographic - Agitation Associated With Alzheimer’s Dementia (AAD): A Focus On Stigma: https://go.psychu.org/KmQZ•PsychU Webinar - Addressing Inequalities In Agitation Among Disinvested Communities With Alzheimer’s Disease: https://go.psychu.org/KmRF•PsychU Webinar - New ICD-10-CM Dementia Codes For Agitation In Alzheimer’s Dementia: https://go.psychu.org/KmRL•PsychU Video - Agitation Associated With Alzheimer’s Dementia: Mechanism Of Disease: https://go.psychu.org/KmRR•PsychU Webinar - Burden & Treatment Considerations For Agitation Associated With Alzheimer’s Dementia: https://go.psychu.org/KmRU•PsychU Webinar - Pathophysiology Of Agitation Associated with Alzheimer’s Dementia: The Potential Role Of The Norepinephrine, Serotonin, & Dopamine (NSD) Neurotransmitter Systems: https://go.psychu.org/KmRYMarc Agronin, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc Amica Simmons-Yon & Aneta Fornal are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.
Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on The Holiday Blues with special guest, Bennett Doughty, PharmD, BCPS, BCPP. During this episode, Dr. Doughty discusses mental health during the holiday season. Whether that’s a worsening of a pre-existing condition or an emergence of new symptoms, Dr. Doughty walks us through some of the most common experiences and what we can do about them to persevere. Lastly, Dr. Doughty shares some key resources with listeners and where they can read more about this topic!Featuring: • Bennett Doughty, PharmD; Clinical Assistant Professor, Department of Pharmacy Practice, Binghamton School of Pharmacy and Pharmaceutical Sciences• Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDCResources:• PsychU Article - Will Consumers Add Health Services To Their Holiday Shopping List? : bit.ly/3vQ0ZrT• PsychU Community Podcast - Burnout & Managing Stress: bit.ly/3QvHZsb• PsychU Article - Over Half Of Adults In The U.S. Are Considered ‘Lonely’: bit.ly/3Gvl6kc• PsychU Article - Severe Loneliness Can Increase Health Care Costs By Over $300 Per Month: bit.ly/3XkNtZg• PsychU Article - Is Loneliness The Overlooked Social Determinant?: bit.ly/3imjTnl• PsychU Video - Digital Technologies For Substance Use Disorder: bit.ly/3WVWyYH• PsychU Downloadable Resource - Substance Use Disorders & Mental Health: bit.ly/3jWP4pr• PsychU Downloadable Resource - Fact Sheet: The Eight Dimensions of Wellness: bit.ly/3XkNQ66• PsychU Resource Library - Suicide Awareness: bit.ly/3XkNRHcDisclaimers:Bennett Doughy, PharmD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, IncAmica Simmons-Yon & Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.©2023 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.
Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on The Holiday Blues with special guest, Bennett Doughty, PharmD, BCPS, BCPP. During this episode, Dr. Doughty discusses mental health during the holiday season. Whether that’s a worsening of a pre-existing condition or an emergence of new symptoms, Dr. Doughty walks us through some of the most common experiences and what we can do about them to persevere. Lastly, Dr. Doughty shares some key resources with listeners and where they can read more about this topic!Featuring: •Bennett Doughty, PharmD; Clinical Assistant Professor, Department of Pharmacy Practice, Binghamton School of Pharmacy and Pharmaceutical Sciences•Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC •Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC Resources: •PsychU Article - Will Consumers Add Health Services To Their Holiday Shopping List? : bit.ly/3vQ0ZrT •PsychU Community Podcast - Burnout & Managing Stress: bit.ly/3QvHZsb •PsychU Article - Over Half Of Adults In The U.S. Are Considered ‘Lonely’: bit.ly/3Gvl6kc •PsychU Article - Severe Loneliness Can Increase Health Care Costs By Over $300 Per Month: bit.ly/3XkNtZg •PsychU Article - Is Loneliness The Overlooked Social Determinant?: bit.ly/3imjTnl •PsychU Video - Digital Technologies For Substance Use Disorder: bit.ly/3WVWyYH •PsychU Downloadable Resource - Substance Use Disorders & Mental Health: bit.ly/3jWP4pr •PsychU Downloadable Resource - Fact Sheet: The Eight Dimensions of Wellness: bit.ly/3XkNQ66 •PsychU Resource Library - Suicide Awareness: bit.ly/3XkNRHcDisclaimers:Bennett Doughy, PharmD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc Amica Simmons-Yon & Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Suicide Awareness & Prevention with special guest, Dr. Mauricio Tohen. During this episode, Dr. Tohen highlights the importance of suicide awareness and prevention. He will discuss current trends in mental health and suicide rates, and specific behaviors and triggers that increase risk of suicide especially concerning youth/adolescents and individuals living with bipolar disorder. Our special guest will even spill the tea on where we can find helpful resources on our efforts in Suicide Awareness and Prevention!
Dr. Mauricio Tohen is a Distinguished University Professor at the University of New Mexico and the Chairman of the University of New Mexico’s Department of Psychiatry and Behavioral Sciences. He has more than 350 publications, 20,000 scientific citations, several books, and prestigious awards to his name. Dr. Tohen has also been recognized as one of the world’s leading experts on bipolar disorder on the breadth and depth of his publications, and one of 100 scientists worldwide recognized in the Psychiatry/Psychology category.
Featuring: • Mauricio Tohen, MD, DrPH, MBA; Professor & Chairman at the University of New Mexico Health Sciences Center Department of Psychiatry • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC
Links:
PsychU - Suicide Awareness: https://bit.ly/3zUA003
PsychU - Bipolar Disorder: https://bit.ly/3JXPJA8
PsychU - Suicide Prevention Brochure: https://bit.ly/3w0PM8h
PsychU - Youth Suicide Prevention - Jonathan Singer: https://bit.ly/3bSaSz4
Home | AFSP: https://afsp.org/
PsychU - Hot Topics: Clinical Questions In Bipolar Disorder (Part 1): https://bit.ly/3QA4eMk
PsychU - A Shot For Bipolar I Disorder? Identifying Appropriate Patient Profiles For Maintenance Therapy With Long Acting Injectable Medications: https://bit.ly/3C2HDV0
PsychU - California, Georgia, Indiana, New Jersey, Oklahoma & Virginia Saw Increase In Adolescent Suicides During COVID-19: https://bit.ly/3bT6hN0
PsychU - Children & Adolescents Experiencing Double The Rate Of Depression & Anxiety Due To COVID-19: https://bit.ly/3PmIHWq
Mauricio Tohen is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc
Amica Simmons-Yon & Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on the impact of racism in the mental healthcare community with special guest, Dr. Gonzalo Gonzalez. As we know, the effects of racism are not confined to patients alone--but also impacts mental health professionals and researchers. During this episode, Dr. Gonzalez will highlight a recent webinar featuring himself and Dr. Napoleon Higgins where they discussed barriers that healthcare professionals experience, including BIPOC and other marginalized groups. Dr. Gonzalez will also discuss his personal experience with racism, where we’ve been, where we are currently, and strategies the health care and research communities are implementing to address some of these challenges.
Dr. Gonzalez currently is a Nephrology Clinical & Scientific Liaison in Medical Affairs at Otsuka Pharmaceutical Development & Commercialization, Inc. He most recently served as a COVID-19 Medical & Scientific Expert for the CDC Foundation and was a leader for Prevention & Control at the City of Detroit Health Department.
Featuring:
• Gonzalo Gonzalez, DNP, APRN, NP-C Nephrology Clinical & Scientific Liaison, Otsuka Pharmaceutical Development & Commercialization, Inc. • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC
Links:
PsychU - The Effects Of Racism On The Mental Healthcare Community: How Marginalized Patients & Providers Are Impacted: https://psychu.org/the-effects-of-racism-on-the-mental-healthcare-community-how-marginalized-patients-providers-are-impacted/
PsychU - Diversity, Equity, & Inclusion: https://bit.ly/3QC4KJZ
PsychU - Impact & Trauma Of Racism: https://bit.ly/3phceqc
PsychU - Lifespan Impact Of Racism-Related Stress: https://bit.ly/3AhPFHY
PsychU - Intergenerational Effects Of Racism: https://bit.ly/3w0ndrI
PsychU - The 12 Steps To Inclusivity In Mental Health Services Infographic: https://bit.ly/3zSAXGf
PsychU - Call To Action: The Need For Stigma Awareness In Healthcare Professional Education: https://bit.ly/3dludsF
Suicide & Black Americans: Statistics, Faith, & Contextual Competence: https://bit.ly/3pgoJSO
PsychU - Spotlight On Minority Mental Health Month: A Conversation With Dr. Napoleon B. Higgins Jr.: https://bit.ly/3BYr5x5
Amica Simmons-Yon, Alyssa Peckham, and Gonzalo Gonzalez are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Minority Mental Health Awareness with special guest, Dr. Carolyn Jones. During this episode, Dr. Jones highlights the importance of mental health awareness in minority communities, educational gaps and needs within the mental health space, and opportunities to reduce stigma amongst minority men for optimal mental wellness. Dr. Jones most recently retired from Otsuka as a Senior Medical Science Liaison after 22 years of providing medical education and resources to healthcare professionals. Currently, Carolyn Jones, PhD stays active and very busy as a Board Member for NAMI Florida, which is the state affiliate of the National Alliance on Mental Illness.
Featuring: • Carolyn Jones, PhD; Board Member of NAMI Florida, state affiliate of the National Alliance on Mental Illness • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC
Links:
PsychU - Diversity, Equity, & Inclusion: https://bit.ly/3w0UXoL
PsychU - The Effects Of Racism On The Mental Healthcare Community: How Marginalized Patients & Providers Are Impacted
PsychU - 2022 BIPOC Mental Health Month Toolkit: https://bit.ly/3PiPn8g
PsychU - Intergenerational Effects Of Racism: https://bit.ly/3AfTVb0
PsychU - Call To Action: The Need For Stigma Awareness In Healthcare Professional Education: https://bit.ly/3C1AbJu
PsychU - Suicide & Black Americans: Statistics, Faith, & Contextual Competence: https://bit.ly/3JXoxBp
PsychU - Spotlight On Minority Mental Health Month: A Conversation With Dr. Napoleon B. Higgins Jr.: https://bit.ly/3QgLRwi
PsychU - Impact & Trauma Of Racism: https://bit.ly/3AkAsGp
Carolyn Jones is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc
Amica Simmons-Yon & Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Disaster Psychiatry with special guest, Richard Weisler, MD. During this episode, Dr. Weisler discusses mental health during times of political unrest in light of the current events taking place in Europe. He will highlight an increased need for mental health services during times of disaster, focusing on trauma, post-traumatic stress disorder, and living with uncertainty. Lastly, Dr. Weisler shares key resources with listeners and where they can read more about this topic!
Featuring: • Richard Weisler, MD; Psychiatrist, Richard H. Weisler, MD & Associates; Adjunct Professor of Psychiatry, University of North Carolina at Chapel Hill School of Medicine; Adjunct Associate Professor of Psychiatry & Behavioral Sciences, Duke University Medical Center • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC
Links:
PsychU Interview | Access To Psychiatric Medications During Times of Natural Disasters & Pandemics: https://bit.ly/3zDarSI
Two-part series on “Psychiatry Perspectives On COVID-19” • PsychU Webinar | Part 1 – Impact on Health Care Providers & First Responders And A Path Forward: https://bit.ly/3NQDFBV • PsychU Webinar | Part 2 – Patient Care In A Post-Pandemic World: https://bit.ly/39uB9SD
Two-part series on “Emergency Relief Series” • PsychU Webinar | Part 1 – Mental Health Considerations After A Natural Disaster: Clinical Pearls For Those In Nature’s Path: https://bit.ly/39wSbzz • PsychU Webinar | Part 2 – Psychiatric Illness Identification & Treatment For Mass Casualty Event Survivors & First Responders: https://bit.ly/3zAaX3R
Nine-part series on “After a Natural Disaster or Tragedy” • PsychU Interview | Part 1 – Preparing For & Providing Mental Health Services: https://bit.ly/3xvUZ84 • PsychU Interview | Part 2 – Serving As A Relief Volunteer: https://bit.ly/3zyq8dP • PsychU Interview | Part 3 – Mental Health Awareness Following A Mass Shooting: https://bit.ly/3xQ0jof • PsychU Interview | Part 4 – Engendering Resiliency & Perseverance: https://bit.ly/3zEAU2a • PsychU Interview | Part 5 – Debriefing & Self-Care For Health Care Professionals: https://bit.ly/3xNC6is • PsychU Interview | Part 6 – Psychiatric Distress Presenting In Primary Care: https://bit.ly/3b5ojLn • PsychU Interview | Part 7 – Psychiatry Following A Mass Casualty Incident: https://bit.ly/3xuSTWc • PsychU Interview | Part 8 – Behavioral Health Response Immediately Following A Mass Shooting: https://bit.ly/3MUR5eC • PsychU Interview | Part 9 – Long-Term Behavioral Health Services In Response To A Mass Shooting: https://bit.ly/3xpEg6A
Richard Weisler is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc
Amica Simmons-Yon & Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
US.CORP.X.22.00207
Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Decriminalizing Mental Health with special guest, Caroline Fisher-O’Neill, Esq. During this episode, Caroline informs us on the meaning of “criminalization of mental health” so that we can better understand this disparity. She provides us with some examples of disproportionate criminalization and highlights what is currently being done to swing the pendulum in the opposite direction to decriminalize mental health. Excitedly, Caroline lets us know where we can find more resources on this topic!
Featuring:
Caroline Fisher-O’Neill, Esq.; Director, State Government Affairs, OAPI Caroline Fisher-O’Neill is the East Director for State Government Affairs at Otsuka. Prior to joining this team, nearly 10 years ago, she worked in the Massachusetts State Legislature on health policy. Serving as the General and Health Policy Counsel to the Senate Chair of the Healthcare Finance Committee, and later as Health Policy Counsel to the Speaker of the House, she gained a significant amount of exposure to the challenges inherent in the healthcare policy landscape. In her current role, she works with the GA team to drive open access to treatments and services for Otsuka’s patient populations and leads initiatives to support Otsuka’s commitment to helping individuals with serious mental illness. She resides in Brooklyn, NY.
Amica Simmons-Yon, PharmD, PhD Clinical & Scientific Liaison, Otsuka Pharmaceutical Development and Commercialization, Inc.
Alyssa Peckham, PharmD, BCPP Clinical & Scientific Liaison, Otsuka Pharmaceutical Development and Commercialization, Inc.
Links:
PsychU Interview | Decriminalizing Mental Illness: https://bit.ly/3Nm04WP
PsychU Article | Baton Rouge Area Foundation Plans to Create Community Mental Health Diversion Center: https://bit.ly/3PtZGHW
PsychU Article | Oregon Law To Decriminalize Drug Use Goes Into Effect, Offering Addiction Treatment Instead Of Incarceration: https://bit.ly/3lnLa6w
PsychU Article | Federal Appeals Court Prohibits Arresting Homeless People For Sleeping In Public When Shelter Beds Are Insufficient: https://bit.ly/3Ptv0GF
PsychU Article | Connecticut, New Mexico, New York & Virginia Legalized Recreational Use of Marijuana in 2021: https://bit.ly/3FVuTiP
Caroline Fisher-O’Neill, Amica Simmons-Yon and Alyssa Peckham are employees of Otsuka America Pharmaceutical, Inc
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
US.CORP.X.22.00154
Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Managed Care & Value-Based Reimbursement with special guest, Madeline Shurtleff, PharmD. During this episode, Dr. Shurtleff highlights the difference between individual health plans and pharmacy benefit managers (PBMs), and how that differs among private insurers versus federal. She also tunes us into the inner workings of the two – namely, how they interact with one another and how decisions are made to deliver your health care. Lastly, Dr. Shurtleff let’s us know where we can find more information on managed care topics!
Dr. Shurtleff graduated from the University of Rhode Island College of Pharmacy. She started her pharmacy career as a pharmacist at Walgreens before transitioning to managed care. Her managed care experience includes managing utilization management pharmacist teams for various Medicare, Medicaid, and Dual Eligible Special Needs Plan (D-SNP) health plans. As a Managed Market Liaison with Otsuka, she helps to bridge clinical, economic, and disease state information to support better health outcomes for patients. She resides in Phoenix, Arizona.
Featuring: • Madeline Shurtleff, PharmD; Managed Market Liaison, OPDC • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC
Links:
PsychU Article | Ready, Set, Managed Care! https://bit.ly/3M6Oz4V
PsychU Article | Medicaid Managed Care – From 0 To 100: https://bit.ly/3jLOeZv
PsychU Interview | Mental Health & COVID-19: Managed Care Perspective: https://bit.ly/3jFWbzi
PsychU Article | Collaboration Between Managed Care & Mental Health Staff: Does It Improve Outcomes? https://bit.ly/3xAsUOD
PsychU Article | Medicare Managed Care Is On The Increase – At Consumer Request: https://bit.ly/3JRhk41
Madeline Shurtleff, Amica Simmons-Yon, and Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
US.CORP.X.22.00133
Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on the hot topic of “medication adherence in Bipolar I Disorder”, with special guest, Dr. Joseph Goldberg. During this episode, Dr. Goldberg discusses the challenges of adherence in BP l Disorder. Our special guest will even spill the tea on where we can find more resources on this topic!
Featuring: Joseph Goldberg, MD Dr. Joseph Goldberg is a Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai, is Director of the Affective Disorders Research Program at Silver Hill Hospital in New Canaan, CT, and serves as a Bipolar Section Advisor for PsychU. He has published several books and hundreds of peer-reviewed papers on topics related to the clinical features of bipolar disorder and psychopharmacology. Dr. Goldberg is a Distinguished Fellow of the American Psychiatric Association and has been listed for many years in Best Doctors in America and Castle Connolly's "America's Top Doctors." Amica Simmons-Yon, PharmD, PhD Clinical & Scientific Liaison, OPDC Alyssa Peckham, PharmD, BCPP Clinical & Scientific Liaison, OPDC
Links:
PsychU | Impact of Adherence on Patients with BP I Disorder: https://bit.ly/3LoqMxz
PsychU | Discussion Of Identifying Profiles Of Patients With Bipolar I Disorder Who Would Benefit From Maintenance Therapy With A Long-Acting Injectable Antipsychotic: https://bit.ly/38cuTyd
PsychU | A Shot For Bipolar I Disorder? Identifying Appropriate Patient Profiles For Maintenance Therapy With Long Acting Injectable Medications: https://bit.ly/3iG82wC
PsychU | A Look At Adherence In Bipolar Disorder: https://bit.ly/3LgrIn2
PsychU | Treatment Adherence In Mental Health: https://bit.ly/3DgC7wg
PsychU | Bipolar Section Advisor Perspective On The COVID-19 Pandemic An Interview With Dr. Joseph Goldberg: https://bit.ly/36SDW6y
Research-based Expertise in the Psychopharmacology of Mood Disorders (josephgoldbergmd.com): https://bit.ly/3uD0ssg
DBSA - Depression and Bipolar Support Alliance (dbsalliance.org): https://bit.ly/36yaLpD
Joseph Goldberg is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc
Amica Simmons-Yon & Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
US.CORP.X.22.00155/
Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Psychiatric Advance Directives with special guest, Dr. Leon Ravin. During this episode, Dr. Ravin highlights Psychiatric Advance Directives, its value to the patient at the time of a psychiatric crisis and the impact of the document on the therapeutic alliance and patient outcomes. Dr. Ravin is a Psychiatrist and Statewide Psychiatric Medical Director for the Division of Public and Behavioral Health, State of Nevada. He is an educator and serves in key committees on the National Association of State Mental Health Program Directors, SMI Advisor (an APA and SAMHSA initiative), and the National Psychopharmacology Update.
US.CORP.X.22.00092
Featuring: • Leon Ravin, MD; Co-Founder of Progressive Therapeutics • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC
Links:
PsychU| Psychiatric Advance Directives Fact Sheet: https://bit.ly/3isYlBB
PsychU| Psychiatric Advance Directives – An Introduction: https://bit.ly/36IcsQT
PsychU| Psychiatric Advance Directives – A Deep Dive: https://bit.ly/3D3mgRQ
PsychU: Psychiatric Advance Directives – Logistic Nuts & Blots: https://bit.ly/3qxCbCL
NAMI| Psychiatric Advance Directives: https://bit.ly/3It3Gnj
National Resource Center for Psychiatric Advance Directives: https://bit.ly/3542rgv
Leon Ravin is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc
Amica Simmons-Yon & Alyssa are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Digital Health & Telepsychiatry with special guest, Dr. Nimish Shah. During this episode, Dr. Shah highlights the pros and cons of telehealth while discussing ways to deliver high quality psychiatric care. Dr. Nimish Shah is a co-founder and provider at Progressive Therapeutics where he has a longstanding commitment to excellence in delivery of patient care. In practice, Dr. Shah teaches the art and science of 21st century mental health care to master’s level nursing students from Northeastern University. He also plays a key role at PsychU.org as a clinical expert on the speakers bureau providing resources to the professional community.
Featuring: • Nimish Shah, DNP; Co-Founder of Progressive Therapeutics • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC
Links:
Progressive Therapeutics allays telehealth security concerns with EHR integration | Healthcare IT News: https://bit.ly/3L4TyU7
Dr. Nimish Shah DNP - PTX: https://bit.ly/3gggdP9
PsychU | Ready For The Digital Health Revolution? Note: It’s Not Just Telehealth: https://bit.ly/3gj0uPo
PsychU | Privacy & Security In Digital Health: https://bit.ly/3okfOj8
PsychU | Navigating Telepsychiatry In Mental Health Care: A Discussion With A Peer Specialist & A Caregiver: https://bit.ly/3Gm99eo
PsychU | Telepsychiatry In Mental Healthcare: Potential Benefits & Guidelines: https://bit.ly/3HoBceE
Nimish Shah is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc
Amica Simmons-Yon is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Alyssa Peckham is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Dennis Sholler, PhD as they spill the tea on adherence in schizophrenia with special guest, Kathy Day. During this episode, Kathy Day highlights a recent interview where she discusses the most important factors that impact adherence from a patient and caregiver perspective. Kathy is a caregiver and a mental health advocate; she also plays a key role in PsychU.org as Section Advisor of the Patient & Caregiver Resource Center.
Featuring: • Kathy Day, MPA, BA, AA; Patient & Caregiver Section Advisor • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Dennis Sholler, PhD; Clinical & Scientific Liaison, OPDC
mentalhealth
PsychU | Patient & Caregiver Resource Center https://bit.ly/3nvh6I2
PsychU | Adherence In Schizophrenia: A Patient & Caregiver Perspective https://bit.ly/3FsNh14
Kathy Day is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc
Amica Simmons-Yon is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Dennis Sholler is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Aneta Fornal, PharmD as they spill the tea about this week’s hot topic on insights around Suicide & Black Americans with special guest, Sherry Molock, PhD, LCSW. Dr. Molock is an Associate Professor in the Department of Psychological & Brain Sciences at The George Washington University. Dr. Molock has over 20 years of experience in suicide prevention among Black American communities and is a founding pastor of the Beloved Community Church in Maryland. Join the PsychU Podcast team this week and learn more about Suicide & Black Americans.
Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC CSL • Aneta Fornal, PharmD, OPDC Sr. CSL • Sherry Molock, PhD, M.Div., Associate Professor, George Washington University
PsychU | Suicide & Black Americans: Statistics, Faith, & Contextual Competence: https://bit.ly/3jKRQeD
PsychU | Suicide Awareness: https://bit.ly/3blQ9Q4
PsychU | Addressing Racial Bias In Health Care: Practice & Organizational Perspectives: https://bit.ly/3vULIFF
PsychU | Diversity, Equity, & Inclusion: https://bit.ly/3jN9hLH
Home | AFSP: https://bit.ly/3Gth4YB
Suicide Prevention Resource Center: https://bit.ly/3w0pOkb
Amica Simmons-Yon and Aneta Fornal are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Sherry Molock is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week’s hot topic in celebration of Pharmacists Month. With special guests Dr.’s Ehret and Silvia, they will discuss what’s going on in the Pharmacist Corner and explain the role of pharmacists in depression management.
Megan Ehret, PharmD, MS, BCPP is a psychiatric pharmacist and a Professor at the University of Maryland School of Pharmacy. Dr. Ehret is also the Past-President of CPNP and the current Section Editor for the Pharmacist Corner on PsychU. Richard Silvia, PharmD, BCPP is Professor at the Massachusetts College of Pharmacy and Health Sciences. Dr. Silvia maintains a practice site at the Codman Square Health Center, in Dorchester, MA. Join the PsychU Podcast team this week and learn more about the role of Pharmacists in depression management.
Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC Sr. MSL • Megan Ehret, PharmD, MS, BCPP • Richard Silvia, PharmD, BCPP
MDD #PharmacistsMonth #PharmD
The Role Of The Pharmacist In The Treatment Of Depression - PsychU: https://bit.ly/3peY7ms
Suicide Stratification Risk Models & The Role Of Pharmacists In Suicide Education & Prevention - PsychU: https://bit.ly/30xH9VX
Pharmacist Corner - PsychU: https://bit.ly/3jdtudn
Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Megan Ehret and Richard Silvia are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
US.CORP.X.21.00677
Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Aneta Fornal, PharmD as they spill the tea about this week’s hot topic on the mission and insights around Youth Suicide Prevention with special guest, Jonathan Singer, PhD, LCSW. Dr. Singer is an Associate Professor in the School of Social Work at Loyola University Chicago, and he is the founder and host of the award-winning Social Work Podcast. Honorably, Dr. Singer most recently served as the former President of the American Association of Suicidology. Join the PsychU Podcast team this week and learn more about Youth Suicide Prevention.
Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC Sr. MSL • Aneta Fornal, PharmD, OPDC Sr. MSL • Jonathan Singer, PhD, LCSW; Associate Professor, Loyola University Chicago
Suicide Awareness - PsychU • https://bit.ly/3zTSbRy
PsychU | Suicide & Black Americans: Statistics, Faith, & Contextual Competence • https://bit.ly/3m7abTw
For Better Or Worse? Bridging The Care Continuum For Mental Health Services In Our New Reality - PsychU • https://bit.ly/3kTc6LT
https://socialworkpodcast.com • https://bit.ly/3F3Akvd
If you or someone you know is in crisis, please contact the Suicide Prevention Hotline / Lifeline at 1-800-273-TALK (8255), or text the Crisis Text Line at 741-741
Amica Simmons-Yon, Jacquelyn Canning and Aneta Fornal are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Jonathan Singer is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week’s hot topic: Neuroimaging in Schizophrenia with a special guest, Anissa Abi-Dargham, MD. Dr. Abi-Dargham is the Vice-Chair of Research, Department of Psychiatry & Behavioral Health, Stony Brook University. Join the PsychU podcast team this week and learn more about updates in neuroimaging in schizophrenia and future directions in research.
Featuring:
• Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC Senior MSL • Anissa Abi-Dargham, MD
Neuroimaging Updates In Schizophrenia & The Future Of Precision Medicine: An Interview With Dr. Anissa Abi-Dargham - PsychU https://bit.ly/3AV0b5L
Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Anissa Abi-Dargham, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week’s hot topic on the vision and mission of NEI to educate psychiatric and neurologic professionals, with a special guest, Sabrina Segal. NEI is a supporting organization of PsychU and was started over 20 years ago by Dr. Stephen Stahl, with the desire to help professionals. Dr. Sabrina Segal is the medical writer for the Neuroscience Education Institute, where she helps educate professionals around the world on novel research. With honor, she is also the host of NEI Podcast. Join the PsychU podcast team this week and learn more about the phenomenal resources that NEI has for the mental health community.
Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC MSL • Sabrina Segal, PhD, Medical Writer of NEI Links:
https://psychu.org/
https://www.neiglobal.com/
https://neiglobal.libsyn.com/ Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Sabrina Segal is a paid employee of Neuroscience Education Institute (NEI), which is a supporting organization of PsychU
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week’s hot topic: STARR Coalition with a special guest, Luke Kramer. Mr. Kramer is the Executive Director of the STARR Coalition which is a forum for the leaders in mental health clinical research, advocacy, treatment, and individuals being served to work together to create a better system of care. Their primary goals are stigma reduction, protection of individual rights, and promotion of research as a viable option in the continuum of care. Join the PsychU podcast team this week and learn more about the STARR Coalition.
Featuring:
• Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC Senior MSL • Luke Kramer, Executive Director of STARR Coalition
The STARR Coalition Seeks To Destigmatize Mental Health Research Through Innovative Initiatives & Programs - PsychU https://bit.ly/3ma25es
The STARR Coalition Supports Mental Health Clinical Research By Fostering Goodwill Among Stakeholders & Trust Within Communities - PsychU https://bit.ly/3gaAO7I
Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Luke Kramer is a consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week’s hot topic: Workplace Mental Health with a special guest, Gaurava Agarwal, MD. Dr. Agarwal is an Associate Professor in the Department of Psychiatry and the Behavioral Sciences, Associate Professor of the Department of Medical Education, the Director of Physician Well-Being for Northwestern Medicine’s Medical Groups, and Director of Undergraduate Medical Student Education in Psychiatry at Northwestern University Feinberg School of Medicine in Chicago, IL. He also serves as PsychU’s Major Depressive Disorder Section Advisor. Join the PsychU podcast team this week and learn more about Workplace Mental Health.
Featuring:
• Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC Senior MSL • Gaurava Agarwal, MD
PsychU Major Depressive Disorder Section https://bit.ly/2VTXW3L
Building Better Beings: PsychU Supporting Organizations Share Wellness Strategies - PsychU https://bit.ly/3z9rKrz
The Impact Of Pandemics On Well-being: Implications For Healthcare Systems & Providers - PsychU https://bit.ly/3gcMas1
Managing Mental Health During & In The Aftermath Of A Pandemic: Positive Changes From The Current Epidemic - PsychU https://bit.ly/3jWNEYu
Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Gaurava Agarwal is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week’s hot topic on the vision, mission, and initiatives of Mental Health America with a special guest, America Paredes. Ms. Paredes is the Vice President of Partnerships & Community Outreach at Mental Health America, with more than 20 years of field experience. In her current role, she leads the development and cultivation of strategic alliances to leverage MHA’s expertise and forward-thinking of the Before Stage 4 philosophy. MHA’s work is driven by its commitment to promote mental health as a critical part of overall wellness. Join the PsychU podcast team this week and learn more about the phenomenal initiatives that MHA has for the community.
Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC MSL • America Paredes, VP of Partners & Community Outreach at MHA
Mental Health Awareness Month 2021 Toolkit - PsychU: https://bit.ly/3yMe45k
National Certified Peer Specialists (NCPS) - PsychU: https://bit.ly/3m4GGTU
Mental Health America | Homepage | Mental Health America (mhanational.org): https://bit.ly/3AEIFlR
In the Open Podcast | Mental Health America (mhanational.org): https://bit.ly/37BZHVv Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Alison Carroll is a paid employee of Mental Health America organization, which is a supporting organization of PsychU
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Topics to be discussed: 1. What is racial trauma, and does it show up in the workplace amongst our providers? 2. As a Black professional yourself, what challenges do Black MH providers face in the workplace and how does it impact the providers mental health? 3. What are the best strategies for Black providers to use when they encounter racial trauma and workplace stress? 4. What can organizations and employers do to provide support to Black MH providers who experience workplace stress or trauma? 5. What resources do you want to highlight on PsychU?
Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week’s hot topic: Racial Trauma in the Workplace with a special guest, Kirby Patmon Williams, PMHNP-BC. Mrs. Williams is a psychiatric nurse practitioner at RBHA in Richmond, VA. She mentors graduate nursing students at various universities across the country and is an adjunct professor at VCU. Kirby is a current member of the American Psychiatric Nurses Association (APNA) and is the founder of the Black PMHNP Collective of Virginia. Join the PsychU podcast team this week and learn more about addressing stress and racial trauma to improve workplace mental health.
Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC MSL • Kirby Patmon Williams, MSN, PMHNP-BC
Addressing Racial Bias In Health Care: Practice & Organizational Perspectives - PsychU https://bit.ly/2VNLVwB
Impact & Trauma Of Racism - PsychU https://bit.ly/3scOEvl
Take A Stand On Racial Injustice: Perspectives From Mental Health Experts In Advocacy And Psychiatric Health Care - PsychU https://bit.ly/3sb9D1r
Kirby Patmon Williams is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week’s hot topic: PsychU Nurses Corner with a special guest, Sara Jones, PhD, APRN, PMHNP-BC, FAANP. Dr. Jones is a psychiatric nurse practitioner and teaches as a tenured professor of nursing at University of Arkansas. She also owns her own practice in Little Rock and serves as a section advisor for PsychU Nurses Corner. Join the PsychU podcast team this week and learn more about psychiatric nursing and PsychU Nurses Corner.
Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC MSL • Sara Jones, PhD, APRN, PMHNP-BC, FAANP
PsychU Nurses Corner https://bit.ly/32VKGew
PsychU Nurses Corner Pearls for Practice: Self Injury, Stigma, & Safety https://bit.ly/3gIpWPJ
PsychU Nurses Corner Pearls for Practice: Insomnia https://bit.ly/3vkHd5C
PsychU Nurses Corner Pearls for Practice: Women's Mental Health and Wellness https://bit.ly/3xBhGXZ
Disclaimers Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Sara Jones is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD as they spill the tea about this week’s hot topic: Recovery-Oriented Perspective & Approach (ROPA) with a special guest, Alison Carroll, LCSW-R. Ms. Carroll is a current member and past president of the New York Association of Psychiatric Rehabilitation Services (NYAPRS) Board. She has also served as board member of the New York State Care Management. Join the PsychU podcast team this week and learn more about the impact of a recovery-oriented perspective & approach in behavioral healthcare.
Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC MSL • Hiten Patadia, PharmD, OPDC MSL • Alison Carroll, LCSW-R
A Recovery-Oriented Perspective & Approach To Behavioral Health Care (ROPA): A Glossary Discussion https://bit.ly/3cvKXdw
A Recovery-Oriented Perspective & Approach To Behavioral Health Care: A Discussion Among A Peer & A Clinical Provider (ROPA Series Part 1) https://bit.ly/3ga9pDD
A Recovery-Oriented Perspective & Approach To Behavioral Health Care: A Discussion Among A Peer & A Clinical Provider (ROPA Series Part 2) https://bit.ly/351XSzT
Amica Simmons-Yon, Hiten Patadia, and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Alison Carroll is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD and Jacquelyn Canning, PharmD, BCPP as they spill the tea about this week’s hot topic: Depression and Bipolar Support Alliance (DBSA) with a special guest, Hannah Zeller, MSW. Ms. Zeller is a program manager for DBSA and has been instrumental in development and creation of the DBSA Mood CrewTM and more! Join the PsychU podcast team this week and learn more about the programs and resources DBSA has to offer.
Featuring: • Amica Simmons-Yon, PharmD, PhD, OPDC MSL • Jacquelyn Canning, PharmD, BCPP, OPDC MSL • Hannah Zeller, MSW
Amica Simmons-Yon and Jacquelyn Canning are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD as they spill the tea about this week’s hot topic: “Cannabis.” Join the discussion by learning more about the mechanism of action, potential risks, and potential benefits of cannabis. Take a peek at a few resources on PsychU to learn more about this exciting topic!
Cannabis: Potential Risks & Benefits In Mental Health – PsychU https://bit.ly/3c3K5x4
Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD as they spill the tea about this week’s hot topic "Substance Abuse Disorder in Psychiatry" with a special guest; Dr. Taca. Dr. Taca is a triple board-certified in Psychiatry, Addiction Medicine, and Preventative Medicine. He is also a distinguished Fellow of the American Society of Addiction Medicine where he served as the president of ASAM - Midwest chapter. Join the PsychU podcast team this week and learn more about his unique practice and the interplay of substance use disorder and psychiatry.
Challenges & Opportunities For Comorbid Substance Use Disorder & Major Depressive Disorder: https://bit.ly/34uZWji Co-Occurrence Of Substance Use Disorders With Mood Disorders & Psychosis: https://bit.ly/3c0fW16
Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD as they spill the tea about this week’s hot topic: “MDD vs Bipolar Disorder.” Join the discussion by learning more about the mechanism of action, potential risks, and potential benefits of cannabis. Take a peek at a few resources on PsychU to learn more about this exciting topic!
Resources:
Is it MDD or Bipolar Disorder? (Distinguishing Bipolar Series Part 1) https://bit.ly/3eV93Ap
Addressing Diagnostic Complexities of Bipolar Disorder (Distinguishing Bipolar Series Part 2) https://bit.ly/2OOy3i7
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors.
Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD as they spill the tea about this week’s hot topic: “Social Determinants of Health.” Join the discussion and learn more about SDoH, the domains of SDoH, and why they are important.
Addressing Social Determinants: Impacting Health & Wellness Beyond Traditional Medicine (SDoH Series Part 1) https://bit.ly/3bBAsEg
How To Build Effective Programs That Meet Payers’ Focus On Social Determinants Of Health: Will The New Codes Pave The Way? (SDoH Series Part 2) https://bit.ly/3svTe6N
Understanding The Role Of Social Determinants In Population Health Management https://bit.ly/3uCRWIX
Disclaimers
Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC
Listen to Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD as they spill the tea about this week’s hot topic: “Burnout and Managing Stress”. Join the discussion and learn more about the methods of evaluating stress, how chronic stress affects the brain, and management strategies.
Avoiding Burnout: Learning To Live & Work Well In Health Care - PsychU • https://bit.ly/3ftUZh9
Managing Mental Health During & In The Aftermath Of A Pandemic: Positive Changes From The Current Epidemic - PsychU • https://bit.ly/3vudh7u
Balancing Act: Preventing Burnout & Establishing Wellness For Health Care Professionals - PsychU • https://bit.ly/3yKmXNh
Balancing Act: Preventing Burnout For Health Care Professionals During The Coronavirus Pandemic & Times Of Crisis - PsychU • https://bit.ly/2QZfjxp
The Impact Of Pandemics On Well-being: Implications For Healthcare Systems & Providers - PsychU • https://bit.ly/3p0QpKE
Disclaimers
Amica Simmons-Yon, PharmD, PhD, Jacquelyn Canning, PharmD, BCPP, and Hiten Patadia, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
MRC2.CORP.X.05762